Porcine factor VIII: Past, present and future

Haematologica

Volumn 85, Issue 10 SUPPL., 2000, Pages 21-25

  Hay, C R M ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; VON WILLEBRAND FACTOR;

BLEEDING; BLOOD TRANSFUSION REACTION; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; HEMOPHILIA; HUMAN; INFECTION RISK; RISK ASSESSMENT; THROMBOCYTOPENIA;

ANIMALS; CONSUMER PRODUCT SAFETY; FACTOR VIII; HEMATOLOGY; HEMOPHILIA A; HUMANS; ISOANTIBODIES; SWINE;

EID: 0033709978     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Polyelectrolyte and preparation of factor VIIIC
2. Clinical experience with polyelectrolyte-fractionated porcine factor VIII concentrate in the treatment of haemophiliacs with antibodies to factor VIII
3. The use of porcine factor VIII: C in the treatment of patients with inhibitor antibodies to VIIIC: A multicenter US trial
4. Safety profile of porcine factor VIII and its use as hospital and home therapy for patients with haemophilia-A and inhibitors: The results of an international survey
5. Use of porcine factor VIII in the treatment of patients with acquired haemophilia
6. Induction of immune-tolerance in patients with haemophilia A and inhibitors treated with porcine FVIII: C by home therapy
7. Interaction of porcine von Willebrand factor with the platelet glycoproteins 1B and IIb/IIIa. complex
8. Platelet activation by porcine factor VIII (Hyate:C)
9. Absence of porcine parvovirus transmission to man
10. Human anti-factor VIII antibodies: Epitope localisation and inhibitory function
11. Analysis of factor VIII inhibitors using hybrid human/porcine factor VIII
12. Coagulant properties of hybrid human/porcine factor VIII molecules